Health5 outlets · 2 countries

Prostate cancer test spots men most at risk of death

This briefing item

First published 23 hours ago (Oct 23, 2026, 8:11 AM UTC) · latest update Oct 23, 2026, 8:11 AM UTC

Independent

Public broadcasters

State-backed

Stance mix in this cluster

Left 0Neutral 4Right 1

Global · 4

United Kingdom · 1

Cross-referenced facts

What more than one outlet reports

Prism keeps a sentence only when at least two write-ups share the same core details. Adjectives that signal a take are stripped. This is not a verdict — it is the overlapping record.

1
Decipher test predicts which high-risk prostate cancer patients benefit from adding abiraterone to treatment.
2 sources: Clinical Lab Products, Pluang

Where coverage diverges2

Claims that appeared in only one write-up, each labeled by outlet.

Medical Xpress · Independent · Global
Diagnostic test could help doctors refine prostate cancer treatment.
Stock Titan · Independent · Global
Researchers will present first evidence that a prostate test predicts who benefits from an added drug.

Each outlet, labeled5

Sources are ordered left → neutral → right so the spread is visible. Stance is a coarse editorial label for comparison, not a moral score. Timestamps are the time each item entered the feed.

Medical Xpress

Global · Independent

Neutral